Global Recombinant Human Thrombopoietin (rhTPO) Market by Type (rhTPO, Fusion Protein), By Application (Medication, Scientific Research) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global recombinant human thrombopoietin (rhTPO) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as increasing prevalence of thrombocytopenia, rising demand for rhTPO in medication and scientific research applications, and growing number of clinical trials for rhTPO products. However, high cost associated with rhTPO therapy is likely to restrain the growth of this market during the forecast period. Based on type, the global recombinant human thrombopoietin (rhTPO) market has been segmented into rhTPO and fusion protein. The fusion protein segment is expected to account for a larger share of the global recombinant human thrombopoietin (rhTPO) market than that of the rh TP O segment duringthe forecast period owingto its higher efficacyand safety profile as compared to other therapies available in this category .On t he basis o f application ,t he m arket has been segmen ted into medication and scientific research applications .



Get Free Sample Report

Product Definition:

A recombinant human thrombopoietin (rhTPO) is a protein that is made in a laboratory using genetic engineering. It is similar to the naturally occurring thrombopoietin, which helps the body produce blood platelets. Recombinant human thrombopoietin (rhTPO) can be used to increase blood platelet counts in people who have low levels of this hormone, such as those with chemotherapy-induced neutropenia or chronic myelogenous leukemia.

rhTPO:

rhTPO is a protein that helps in the formation of blood clots. It also aids in the recovery of damaged blood vessels and plays an important role during times of high stress, injury or surgery. The main function of this protein is to stimulate platelets to release thromboxane which causes them to adhere more closely together and form a larger complex called a thrombus which eventually leads to bleeding.

Fusion Protein:

Fusion protein is a combination of amino acids linked by peptide bonds. It is usually produced in recombinant form and used as an ingredient for the preparation of pharmaceutical products intended for the treatment of thrombocytopenia (low platelet count) and purification or isolation of human TPO.

Application Insights:

rhTPO-based medication held the largest share of over 70.0% in the global market in terms of revenue in 2017. The growing usage of rhTPO as a therapeutic tool for various diseases including Parkinson¢â‚¬â„¢s disease, cancer and diabetes is anticipated to boost product demand during the forecast period.

 This factor is expected to drive product demand during future years when compared with its use as a research tool only due to high patient awareness about these benefits coupled with rising healthcare costs across all regions globally.

Regional Analysis:

North America dominated the global market in 2017. The presence of a large number of rhTPO manufacturers and high adoption rate for new therapies are some factors responsible for its largest share. In addition, increasing FDA approvals and growing demand for blood clotting disorders treatment options are expected to drive the regional market over the forecast period.

Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to rising healthcare expenditure levels, improving infrastructure facilities in developing countries such as China and India, and growing patient awareness levels regarding available treatment options. Moreover, government initiatives encouraging domestic production may also boost rhTPO manufacturing capacity in this region which will subsequently result in an increased supply chain over coming years.

Growth Factors:

Increasing incidence of thrombocytopenia: The global incidence of thrombocytopenia is increasing due to various factors such as aging population, increase in the number of cancer patients, and use of certain medications. This is expected to drive the demand for rhTPO products in the coming years.
Growing awareness about thrombocytopenia: There is growing awareness among people about thrombocytopenia and its treatment options. This is likely to boost the demand for rhTPO products in the near future.
Rising number of clinical trials for rhTPO: A large number of clinical trials are being conducted globally on recombinant human thrombopoietin (rhTPO) products owing to their potential benefits over traditional therapies for treating patients with thrombocytopenia disorders. This is likely to propel the growth of this market in the coming years.


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Recombinant Human Thrombopoietin (rhTPO) Market Research Report
By Type
rhTPO, Fusion Protein
By Application
Medication, Scientific Research
By Companies
Qilu Pharmaceutical, R&D Systems, Merck, Shionogi, MedChemExpress, PeproTech, Kelun, Qilu Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.

Global Recombinant Human Thrombopoietin (rhTPO) Market Report Segments:
The global Recombinant Human Thrombopoietin (rhTPO) market is segmented on the basis of:
Types
rhTPO, Fusion Protein
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medication, Scientific Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Qilu Pharmaceutical
R&D Systems
Merck
Shionogi
MedChemExpress
PeproTech
Kelun
Qilu Pharmaceutical



Get Free Sample Report

Highlights of The Recombinant Human Thrombopoietin (rhTPO) Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
rhTPO
Fusion Protein
By Application:
Medication
Scientific Research
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Recombinant Human Thrombopoietin (rhTPO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?